{"sourcedb":"DevicePMAs@therightstef","sourceid":"P970015_S029","text":"Approval for the addition of the 14mm x 26mm cage titanium lt-cage lumbar tapered fusion device.  The device remains indicated for spinal fusion procedures in skeletally mature patients with degenerative disc disease (ddd) at one level from l2-s1.  Ddd is defined as discogenic back pain with degeneration of the disc confirmed by patient history and radiographic studies.  These ddd patients may also have up to grade i spondylolisthesis or retrolisthesis at the involved level.  Lt-cage devices are to be used with autogenous bone graft and implanted via a laparoscopic or an open anterior approach.  Patients receiving the lt-cage lumbar tapered fusion device should have had at least six months of nonoperative treatment prior to treatment with the lt-cage device.","project":"consensus_PMA_Age_Indications"}